Granules India gets USFDA approval for Butalbital, Acetaminophen, Caffeine Capsules Medical Dialogues Bureau10 April 2020 12:01 PM ISTButalbital, Acetaminophen and Caffeine Capsules are used for the relief of the symptom complex of tension headache.
Granules receives USFDA nod for Potassium Chloride Extended-Release Tablets USP Medical Dialogues Bureau7 March 2020 10:00 AM ISTPotassium Chloride ER Tablets are used for the treatment and prophylaxis of hypokalemia with or without metabolic alkalosis, in patients for whom...
Granules Pharma gets USFDA nod for genetic disorder drug Colchicine Medical Dialogues Bureau8 Feb 2020 10:30 AM IST "The US Food & Drug Administration (USFDA) has approved the Abbreviated New Drug Application (ANDA) filed by Granules Pharmaceuticals, Inc, a...
Granules India gets 2 USFDA observations for Chantilly facility Medical Dialogues Bureau23 Aug 2019 11:46 AM IST"The United States Food and Drug Administration (USFDA) has completed inspection of the facility of Granules Pharmaceuticals Inc, a wholly-owned...
Granules India completes USFDA inspection for Bonthapally facility with one observation Farhat Nasim29 July 2019 10:00 AM ISTGranules India Ltd's Bonthapally facility is one of the world's largest single-site Paracetamol API manufacturing plant by volume. New Delhi: Drug...
Granules India gets USFDA nod for Methylphenidate Hydrochloride ER capsules Farhat Nasim28 May 2019 10:00 AM ISTThe approved product, Methylphenidate Hydrochloride extended-release capsules, is bioequivalent to the reference listed drug product (RLD), Ritalin LA...
Granules gets 2 observation by USFDA for U.S Unit Medical Dialogues Bureau30 Oct 2018 10:48 AM ISTNew Delhi: Pharma firm Granules through a recent regulatory filing announced its US subsidiary has received two observations from the US health...
